Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
101,251,004
-
Share change
-
+3,140,123
-
Total reported value
-
$3,644,068,318
-
Put/Call ratio
-
78%
-
Price per share
-
$35.99
-
Number of holders
-
353
-
Value change
-
+$105,165,687
-
Number of buys
-
187
-
Number of sells
-
166
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2025
As of 30 Jun 2025 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 353 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 101,251,004 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Clearbridge Investments, LLC, Soleus Capital Management, L.P., Pictet Asset Management Holding SA, GOLDMAN SACHS GROUP INC, Hood River Capital Management LLC, and FMR LLC.
This table shows 353 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.